Paul Riska
Impact in
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
- Clostridium difficile and Clostridium perfringens research
- HIV/AIDS drug development and treatment
- Viral gastroenteritis research and epidemiology
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 22
- Mycobacterium research and diagnosis 12
-
- Tuberculosis Research and Epidemiology 12
- Clostridium difficile and Clostridium perfringens research 4
- Co-authors
- William R. Jacobs (9 shared papers)John Chan (4 shared papers)Horatio B. Fung (1 shared paper)David Alland (1 shared paper)Marie L. Landry (1 shared paper)David Ferguson (1 shared paper)John P. Sabo (1 shared paper)Joseph Pav (1 shared paper)
- Journals
- Journal of Clinical Microbiology (8 papers)Antimicrobial Agents and Chemotherapy (2 papers)Microbial Pathogenesis (1 paper)Clinical Infectious Diseases (1 paper)Medicine (1 paper)
- Partner nations
- United StatesMexicoFrance
In The Last Decade
Paul Riska
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 88
- Infectious Diseases 753
- Molecular Medicine 112
- Virology 92
- Applied Microbiology and Biotechnology 39
- Epidemiology 636
Countries citing papers authored by Paul Riska
This map shows the geographic impact of Paul Riska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Riska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Riska more than expected).
Fields of papers citing papers by Paul Riska
This network shows the impact of papers produced by Paul Riska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Riska. The network helps show where Paul Riska may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Riska, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 174 | |
| 2 | 2006 | 121 | |
| 3 | 2009 | 107 | |
| 4 | Molecular determinants of drug resistance in tuberculosis. | 2000 | 80 |
| 5 | 1997 | 79 | |
| 6 | 1999 | 67 | |
| 7 | 2001 | 64 | |
| 8 | 1996 | 61 | |
| 9 | 2011 | 49 | |
| 10 | 2003 | 45 | |
| 11 | 2003 | 44 | |
| 12 | 1997 | 43 | |
| 13 | 2003 | 41 | |
| 14 | 2005 | 40 | |
| 15 | 1990 | 31 | |
| 16 | 2003 | 26 | |
| 17 | 2015 | 17 | |
| 18 | 2002 | 15 | |
| 19 | 2018 | 14 | |
| 20 | 2014 | 13 |
About Paul Riska
Paul Riska is a scholar working on Epidemiology, Infectious Diseases, Ecology, Molecular Biology and Virology, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (12 papers), Bacteriophages and microbial interactions (8 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Bacterial Identification and Susceptibility Testing (3 papers), Reproductive tract infections research (3 papers), HIV Research and Treatment (2 papers) and Poxvirus research and outbreaks (2 papers). The work is most often cited by research in Infectious Diseases (753 citations), Molecular Medicine (112 citations), Virology (92 citations), Applied Microbiology and Biotechnology (39 citations) and Epidemiology (636 citations). Paul Riska has collaborated with scholars based in United States, Mexico and France. Frequent co-authors include William R. Jacobs, John Chan, Horatio B. Fung, David Alland, Marie L. Landry, David Ferguson, John P. Sabo, Joseph Pav, Susan E. Hattox and Michael Lamson. Their work appears in journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy, Microbial Pathogenesis, Clinical Infectious Diseases and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.